Vmn2r24 inhibitors are chemical agents designed to selectively interact with a particular class of chemosensory receptors known as Vmn2r24, which is a subtype of the Vomeronasal type 2 receptor (V2R). These receptors are part of a complex chemoreception system that is distinct from the olfactory receptors typically involved in the detection of volatile odorants. The vomeronasal system, mainly studied in animals, is implicated in the detection of pheromones-chemical signals that carry information between members of the same species. Vmn2r24 receptors are G protein-coupled receptors (GPCRs), which is a large protein family of receptors that sense molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. The inhibition of Vmn2r24 receptors involves the binding of these inhibitors to the receptor, blocking its function and preventing the normal signal transduction pathway from initiating.
The design of Vmn2r24 inhibitors is a sophisticated process that requires a detailed understanding of the molecular structure and functioning of the Vmn2r24 receptor itself. Researchers often employ various techniques such as X-ray crystallography, computational modeling, and mutagenesis to elucidate the binding sites and conformational changes of the receptor upon ligand binding. These studies help in identifying key interactions between the receptor and the inhibitor. The inhibitors are typically small organic molecules that can bind to the receptor with high specificity, often designed to fit snugly into the binding pocket of the Vmn2r24 receptor, blocking the access of the natural ligand. By understanding the exact shape and electronic properties of the receptor site, chemists can synthesize inhibitors that are not only potent but also selective, minimizing the interaction with other GPCRs and reducing off-target effects. The development of these inhibitors provides valuable tools for probing the physiological and biochemical roles of the Vmn2r24 receptor in the complex chemosensory systems of organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
This diuretic compound acts as an inhibitor of epithelial sodium channels. Vmn2r24, being a chemosensory receptor, could be indirectly affected by changes in ionic concentrations and membrane potentials caused by amiloride, leading to altered receptor activity. | ||||||
Spiperone | 749-02-0 | sc-471047 | 250 mg | $130.00 | ||
As a potent dopamine and serotonin antagonist, spiperone can potentially interfere with the signaling pathways that might intersect with Vmn2r24's activities, possibly leading to reduced activation of Vmn2r24. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
A selective blocker of TRPV1, TRPV2, and TRPV3, channels that could interact with Vmn2r24's signaling pathways in sensory neurons, potentially leading to decreased Vmn2r24 activity. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $77.00 $102.00 $163.00 $347.00 $561.00 | 1 | |
Known as an anti-malarial agent, quinine also blocks voltage-gated potassium channels. If Vmn2r24 activity is modulated by potassium channel activity, quinine could indirectly inhibit Vmn2r24. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $80.00 $326.00 | 1 | |
This serotonin antagonist, used to prevent nausea, could theoretically diminish Vmn2r24 activation if the chemosensory receptor is influenced by serotonin pathways. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
It acts as a serotonin and dopamine antagonist. Clozapine's broad receptor activity could reduce signaling in pathways that may contribute to Vmn2r24 activation. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $60.00 | 17 | |
A glucocorticoid receptor antagonist that could impact the expression or activity of various proteins, including Vmn2r24, if glucocorticoid signaling modulates Vmn2r24 activity. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $50.00 $168.00 $520.00 | 2 | |
An alpha-2 adrenergic receptor antagonist that could reduce Vmn2r24's activity by altering adrenergic signaling, which might intersect with the receptor's functional pathways. | ||||||